Background: Liver fibrosis is the result of the chronic hepatocyte damage due to different
causes. Among them, Non-alcoholic Fatty Liver Disease (NAFLD) is estimated to account for …

Type 2 diabetes is a major risk factor for development and progression of non-alcoholic fatty
liver disease (NAFLD). Fatty liver is prevalent in people with type 2 diabetes, and overweight …

Non-alcoholic fatty liver disease (NAFLD) represents a broad spectrum of liver damage,
ranging from simple steatosis to steatohepatitis and fibrosis; as well, there is a close …

Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of a metabolic
syndrome, is a leading cause of chronic liver disease worldwide with prevalence 17-46% in …

Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are
pathological conditions that are co-occurring, and have been reaching epidemic …

Hepatic steatosis (HS) is defined as an intrahepatic fat content of more than 5%. 1 While the
clinical entity of non-alcoholic fatty liver disease (NAFLD) is based on a diagnosis of …

Nonalcoholic fatty liver disease (NAFLD) is a spectrum of disease ranging from simple
steatosis to nonalcoholic steatohepatitis to advanced fibrosis and cirrhosis. This chapter …

The clinical and financial burden of non-alcoholic fatty liver disease (NAFLD) is rising, with a
global prevalence of approximately 25%(1). NAFLD encompasses a wide disease spectrum …

Non-alcoholic fatty liver disease (NAFLD) increases risk of mortality from liver and
cardiovascular disease (CVD) and is the major cause of hepatocellular carcinoma (HCC) …

Patients with type 2 diabetes mellitus (T2DM) are at increased risk of non-alcoholic fatty liver
disease (NAFLD) and might eventually progress to advanced fibrosis, cirrhosis and …